Follicle-stimulating hormone versus anti-Müllerian hormone: age related relevance to intracytoplasmic sperm injection results

Rana M. Ibrahim; Fadia J. Alizzi; Qais A. Alkhafaji

doi:10.18203/2320-1770.ijrcog20263408

Authors

Rana M. Ibrahim Baghdad Teaching Hospital, Baghdad, Iraq
Fadia J. Alizzi AL-Yarmouk Teaching Hospital, Baghdad, Iraq
Qais A. Alkhafaji Kamal Al-Samarrai of Fertility and Sterility Hospital, Baghdad, Iraq

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20263408

Keywords:

Infertility, Maternal age, Anti-Müllerian hormone, Antral follicle count, Ovarian stimulation, Assisted reproductive technology

Abstract

Background: Maternal age significantly impacts ovarian reserve and intracytoplasmic sperm injection (ICSI) outcomes. This study evaluated the influence of maternal age on ovarian reserve parameters and ICSI treatment results.

Methods: This prospective observational cohort study enrolled 100 infertile women (aged 20-43) undergoing ICSI in Baghdad (March 2025-February 2026), stratified by age: Group A (<35 years, n=65) and group B (≥35 years, n=35). Baseline anti-Müllerian hormone (AMH), follicle-stimulating hormone (FSH), estradiol (E2), and AFC were evaluated on cycle day 2-3. All patients received a standardized fixed antagonist protocol.

Results: Women aged <35 years had significantly higher baseline AMH levels than those ≥35 years (2.06±0.94 vs. 1.51±0.82 ng/ml, p=0.004). No significant differences were found in basal FSH (p=0.876), AFC (p=0.070), or E2 (p=0.326). Women aged ≥35 required significantly higher gonadotropin doses (41.0±5.05 vs. 29.3±6.72 ampoules, p<0.001) and longer stimulation (10.4±1.09 vs. 9.63±1.32 days, p=0.003). Retrieved oocytes (6.86±3.59 vs. 7.57±3.09, p=0.302), MII oocytes (p=0.097), and fertilized oocytes (p=0.136) were lower in older women but these differences did not reach statistical significance.

Conclusions: Ovarian responsiveness declines with maternal age, requiring higher gonadotropin doses and prolonged stimulation. Serum AMH is a more sensitive marker than basal FSH for detecting early age-related ovarian decline in ICSI candidates.

References

Zegers-Hochschild F, Adamson GD, Dyer S, Racowsky C, De Mouzon J, Sokol R, et al. The international glossary on infertility and fertility care, 2017. Hum Reprod. 2017;32(9):1786-801.

World Health Organization. Infertility. Available at: https://www.who.int/news-room/fact-sheets/detail/infertility. Accessed on 18 July 2026.

Gat I, Shlush E, Quach K, Librach CL. The continuum of high ovarian response: a rational approach to the management of high responder patient subgroups. Syst Biol Reprod Med. 2015;61(6):336-44.

American College of Obstetricians and Gynecologists Committee on Gynecologic Practice and Practice Committee. Female age-related fertility decline. Committee Opinion No. 589. Fertil Steril. 2014;101(3):633-4.

Crawford NM, Steiner AZ. Age-related infertility. Obstet Gynecol Clin North Am. 2015;42(1):15-25.

Rowe T. Fertility and a woman's age. J Reprod Med. 2006;51(3):157-63.

Tal R, Seifer DB. Ovarian reserve testing: a user's guide. Am J Obstet Gynecol. 2017;217(2):129-40.

La Marca A, Sunkara SK. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice. Hum Reprod Update. 2014;20(1):124-40.

Alviggi C, Andersen CY, Buehler K, Conforti A, De Placido G, Esteves SC, et al. A new more detailed stratification of low responders to ovarian stimulation: from a low ovarian response to a low prognosis concept. Fertil Steril. 2016;105(6):1452-3.

Broekemans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006;12(6):685-718.

Wallace WH, Kelsey TW. Human Ovarian Reserve from Conception to the Menopause. PLoS ONE. 2010;5(1):e8772.

Cahoreau C, Klett D, Combarnous Y. Structure-function relationships of glycoprotein hormones and their subunits' ancestors. Front Endocrinol. 2015;6:26.

Fang T, Su Z, Wang L. Predictive value of age-specific FSH. J Assist Reprod Genet. 2015;32(2):117-25.

Rzeszowska M, Leszcz A, Putowski L, Hałabiś M, Tkaczuk-Włach J, Kotarski J, et al. Anti-Müllerian hormone: structure, properties and appliance. Ginekologia Polska. 2016;87(9):669-74.

Committee on Gynecologic Practice. Committee Opinion No. 618: Ovarian Reserve Testing. Obstet Gynecol. 2015;125(1):268-73.

Liang Y, Huang J, Zhao Q, Mo H, Su Z, Feng S, et al. Global, regional, and national prevalence and trends of infertility among individuals of reproductive age (15-49 years) from 1990 to 2021. Hum Reprod. 2025;4(3):112-20.

Hernáez Á, Rogne T, Skåra KH, Håberg SE, Page CM, Fraser A, et al. Body mass index and subfertility: multivariable regression and Mendelian randomization analyses. Hum Reprod. 2021;36(12):3141-51.

Aanesen A, Westerbotn M. Prospective study of a Swedish infertile cohort 2005-08: population characteristics, treatments and pregnancy rates. Fam Pract. 2014;31(3):290-7.

Chua SJ, Danhof NA, Mochtar MH, Van Wely M, McLernon DJ, Custers I, et al. Age-related natural fertility outcomes in women over 35 years: a systematic review and meta-analysis. Hum Reprod. 2020;35(8):1808-–20.

Maheshwari A, Hamilton M, Bhattacharya S. Effect of female age on the diagnostic categories of infertility. Hum Reprod. 2008;23(3):538-42.

Carson SA, Kallen AN. Diagnosis and management of infertility: a review. JAMA. 2021;326(1):65-76.

Santoro N, Polotsky AJ. Infertility evaluation and treatment. N Engl J Med. 2025;392(11):1111-9.

Hao Y, Yang R, Li J, Zhou Z, Qian W, Zhang J, et al. Age-specific random day serum antimüllerian hormone reference values for women of reproductive age. Am J Obstet Gynecol. 2022;227(6):883-e1.

Penzias A, Azziz R, Bendikson K, Falcone T, Hansen K, Hill M, et al. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2020;114(6):1151-7.

Zeng Y, Zhang Y, Cao Q, Gao Z, Tang T. Independent predictors and thresholds of in vitro fertilization outcomes in patients with diminished ovarian reserve. Sci Rep. 2025;15(1):18875.

Malhotra N, Gupta P, Kamboj S, Chaturvedi P, Kutum R. Age specific variations in ovarian reserves in healthy fertile and infertile women: A cross sectional study. PLoS ONE. 2024;19(10):e0308865.

Polyzos NP, Drakopoulos P, Parra J, Pellicer A, Santos-Ribeiro S, Tournaye H, et al. Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation. Fertil Steril. 2018;110(4):661-70.

Youssef MA, Van Wely M, Al-Inany H, Madani T, Jahangiri N, Khodabakhshi S, et al. A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter trial. Hum Reprod. 2017;32(1):112-8.

Joo BS, Park SH, An BM, Kim KS, Moon SE, Moon HS. Serum estradiol levels during controlled ovarian hyperstimulation influence the pregnancy outcome of in vitro fertilization. Fertil Steril. 2010;93(2):440-6.

Sripada V, Sakkas D, Vaughan D, Morse B, Fouks Y. A high proportion of immature oocytes in a cycle cohort does not compromise embryo development or live birth rates after ICSI. Hum Reprod. 2025;40(12):2318-25.

Pandian Z, Bhattacharya S, Ozturk O, Serour G, Templeton A. Number of embryos for transfer following in-vitro fertilization or intra-cytoplasmic sperm injection. Cochrane Database Syst Rev. 2013;10:CD003416.

Wang X, Jin L, Mao YD, Shi JZ, Huang R, Jiang YN, et al. Evaluation of ovarian reserve tests and age in the prediction of poor ovarian response to controlled ovarian stimulation. Front Endocrinol. 2021;12:702061.

Practice Committee of the American Society for Reproductive Medicine. Comparison of pregnancy rates for poor responders using IVF with mild ovarian stimulation versus conventional IVF: a guideline. Fertil Steril. 2018;109(6):993-9.

La Marca A, Grisendi V, Spada E, Argento C, Milani S, Plebani M, et al. Reference values in ovarian response to controlled ovarian stimulation throughout the reproductive period. Gynecol Endocrinol. 2014;30(1):66-9.

Devesa M, Tur R, Rodríguez I, Coroleu B, Martínez F, Polyzos NP. Cumulative live birth rates and number of oocytes retrieved in women of advanced age: a single centre analysis. Hum Reprod. 2018;33(11):2010-7.

Cimadomo D, Fabozzi G, Vaiarelli A, Ubaldi N, Ubaldi FM, Rienzi L. Impact of maternal age on oocyte and embryo competence. Front Endocrinol. 2018;9:327.

Liu X, Li W, Mol BW, Wen W, Wang T, Tian L, et al. Who may benefit from an increased gonadotropin dosing in predicted poor responders undergoing IVF/ICSI? Eur J Obstet Gynecol Reprod Biol. 2023;291:76-81.

Honnma H, Baba T, Sasaki M, Hashiba Y, Oguri H, Fukunaga T, et al. Different ovarian response by age in an anti-Müllerian hormone-matched group undergoing in vitro fertilization. J Assist Reprod Genet. 2012;29(2):117-25.